4.8 Article

NLRP6 Protects II10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila

Journal

CELL REPORTS
Volume 19, Issue 4, Pages 733-745

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2017.03.080

Keywords

-

Categories

Funding

  1. NIH [R01CA166879, R21CA191744]
  2. American Cancer Society Research Scholar Grant [RSG-11-060-01-MPC]
  3. NIH grants from the National Center for Advancing Translational Sciences [F32CA200144, UL1TR000433]

Ask authors/readers for more resources

Dysfunction in host immune responses and pathologic alterations in the gut microbiota, referred to as dysbiosis, can both contribute to the development of inflammatory bowel disease (IBD). However, it remains unclear how specific changes in host immunity or the microbiota cause disease. We previously demonstrated that the loss of the innate immune receptor NLRP6 in mice resulted in impaired production of interleukin-18 (IL-18) and increased susceptibility to epithelial-induced injury. Here, we show that NLRP6 is important for suppressing the development of spontaneous colitis in the Il10(-/-) mice model of IBD and that NLRP6 deficiency results in the enrichment of Akkermansia muciniphila. A. muciniphila was sufficient for promoting intestinal inflammation in both specific-pathogen-free and germ-free Il10(-/-) mice. Our results demonstrate that A. muciniphila can act as a pathobiont to promote colitis in a genetically susceptible host and that NLRP6 is a key regulator of its abundance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available